How big is the Investigational New Drug CDMO Market?

The Investigational New Drug CDMO Market size is expected to reach USD 4.45 billion in 2024 and grow at a CAGR of 6.55% to reach USD 7.49 billion by 2029. Read More

What is the current Investigational New Drug CDMO Market size?

In 2024, the Investigational New Drug CDMO Market size is expected to reach USD 4.45 billion. Read More

Who are the key players in Investigational New Drug CDMO Market?

Lonza, Charles River Laboratories International, Inc., Recipharm AB, Syneous Health and Labcorp Corporation are the major companies operating in the Investigational New Drug CDMO Market. Read More

Which is the fastest growing region in Investigational New Drug CDMO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Investigational New Drug CDMO Market?

In 2024, the North America accounts for the largest market share in Investigational New Drug CDMO Market. Read More

What years does this Investigational New Drug CDMO Market cover, and what was the market size in 2023?

In 2023, the Investigational New Drug CDMO Market size was estimated at USD 4.16 billion. The report covers the Investigational New Drug CDMO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Investigational New Drug CDMO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Investigational New Drug CDMO Companies

This report lists the top Investigational New Drug CDMO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Investigational New Drug CDMO industry.